Latest Breaking News On - Petera merkel - Page 1 : comparemela.com

The Lupus Approach: CAR-T Begins the Jump from Blood Cancers to Autoimmune Disease

Throughout 2023, interest in the application of CAR-T and other cell therapies to autoimmune disease skyrocketed, with a multitude of clinical trials being initiated by various companies.

United statesDavid porterTiffany chenPetera merkelArtiva biotherapeuticsDavidj changArtiva biotherapeutic alloTom van blarcomNkarta incArtiva biotherapeutics incImmpact bio united states incCabaletta bio incGracell biotechnologies incDivision of rheumatologyKyverna therapeuticsCabaletta bio

Benralizumab Proves Noninferior to Mepolizumab for EGPA

Treatment with benralizumab (Fasenra) achieved remission at 36 and 48 weeks at rates similar to those of mepolizumab (Nucala) in a head-to-head phase 3 trial of the two drugs.

United statesUniversity of pennsylvaniaPetera merkelAmerican college of rheumatologyAmerican collegeBirmingham vasculitis activity scoreVascular damage indexBiologic therapy019 novel coronavirus019 ncovUhan coronavirusUman coronavirus hku1Uman coronavirus oc43Cov oc43Uman coronavirus 229eCov 229e

Kyverna Therapeutics Congratulates Scientific Advisory Board Member Peter A Merkel, M D , M P H on Receiving the 2023 ACR Distinguished Clinical Investigator Award

/PRNewswire/ Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for.

United statesSan diegoPetera merkelPeter maagAmerican college of rheumatologyUniversity of pennsylvaniaPrnewswire kyverna therapeutics incClinical investigator awardAmerican collegeKyverna advisory boardMedia contactKyverna therapeutics

New trials, therapies to address unmet needs in ANCA-associated vasculitis

New trials, therapies to address unmet needs in ANCA-associated vasculitis
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Shenaz baghaPetera merkelPeter merkelByerich martinGenentech rochePenn vasculitis centerBristol myers squibbUniversity of pennsylvaniaPerelman school of medicineClinical rheumatology westClinical rheumatologyPerelman school

We should be thinking cure for giant cell, Takayasu arteritis as trial data grow

We should be thinking cure for giant cell, Takayasu arteritis as trial data grow
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Peter merkelPetera merkelAmgen chemocentryxByrob volanskyGenentech rocheShenaz baghaBristol myers squibbUniversity of pennsylvaniaVessel vasculitisClinical rheumatology westClinical rheumatology